Search research articles
Contact Us
Filters
Showing results (141-150 of 755) with videos related to
Page
of 76
Sort By:
Rheumatology (Oxford, England)
|
October 10, 2017
Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis
Dinesh Khanna, Ron D Hays, Daniel E Furst
Water Research X
|
February 8, 2021
Use of trihalomethanes as a surrogate for haloacetonitrile exposure introduces misclassification bias
Kirin E Furst, Jose Bolorinos, William A Mitch
Open Access Rheumatology : Research and Reviews
|
August 9, 2012
The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
Shatara V Townes, Daniel E Furst, Anuradha Thenkondar
The Korean Journal of Internal Medicine
|
March 3, 2010
Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis
Steven S Storage, Harsh Agrawal, Daniel E Furst
Journal of Pharmaceutical Sciences
|
November 1, 1984
Metabolism of salsalate in normal subjects
S H Dromgoole, D E Furst, H E Paulus
The Journal of Rheumatology
|
October 16, 2004
Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections
David Beenhouwer, Robert Wallis, Michael Broder, et al.
The New England Journal of Medicine
|
March 15, 2018
Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith M Sullivan, Ellen A Goldmuntz, Daniel E Furst
Journal of Chromatography
|
February 24, 1989
Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography
B Nuernberg, M Kohlbrenner, R Faulkner, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 28, 2017
A Case Series on Patients on Tofacitinib in Combination With a Biologic
Nashla S Barroso, Elizabeth Z Miller, Daniel E Furst
Arthritis and Rheumatism
|
November 11, 1999
High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions
P A McSweeney, D E Furst, S G West
Page
of 76
Search research articles
Search
Showing results (141-150 of 755) with videos related to
Sort By:
Page
of 76
Rheumatology (Oxford, England)
|
October 10, 2017
Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis
Dinesh Khanna, Ron D Hays, Daniel E Furst
Water Research X
|
February 8, 2021
Use of trihalomethanes as a surrogate for haloacetonitrile exposure introduces misclassification bias
Kirin E Furst, Jose Bolorinos, William A Mitch
Open Access Rheumatology : Research and Reviews
|
August 9, 2012
The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
Shatara V Townes, Daniel E Furst, Anuradha Thenkondar
The Korean Journal of Internal Medicine
|
March 3, 2010
Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis
Steven S Storage, Harsh Agrawal, Daniel E Furst
Journal of Pharmaceutical Sciences
|
November 1, 1984
Metabolism of salsalate in normal subjects
S H Dromgoole, D E Furst, H E Paulus
The Journal of Rheumatology
|
October 16, 2004
Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections
David Beenhouwer, Robert Wallis, Michael Broder, et al.
The New England Journal of Medicine
|
March 15, 2018
Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith M Sullivan, Ellen A Goldmuntz, Daniel E Furst
Journal of Chromatography
|
February 24, 1989
Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography
B Nuernberg, M Kohlbrenner, R Faulkner, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 28, 2017
A Case Series on Patients on Tofacitinib in Combination With a Biologic
Nashla S Barroso, Elizabeth Z Miller, Daniel E Furst
Arthritis and Rheumatism
|
November 11, 1999
High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions
P A McSweeney, D E Furst, S G West
Page
of 76